Edwards Lifesciences (EW) Tops Q2 EPS by 2c, Guides Above for FY08 Revenues

July 22, 2008 4:11 PM EDT Send to a Friend
Edwards Lifesciences (NYSE: EW) reports Q2 EPS of $0.66 (ex-items), 2 cents better than the analyst estimate of $0.64 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login